Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Korean Journal of Medicine ; : 203-210, 2005.
Artículo en Coreano | WPRIM | ID: wpr-145608

RESUMEN

BACKGROUND: There still is no standard treatment for the patients with advanced hepatocellular carcinoma. Both doxorubicin and cisplatin have modest activity with the response rates less than 20%, but have synergistic effect. This prospective phase II trial was performed to determine the efficacy and toxicity of doxorubicin and cisplatin combination chemotherapy for patients with advanced hepatocellular carcinoma. METHODS: Patients with advanced hepatocellular carcinoma were entered into this study. Eligibility criteria are described below: histologically proven HCC or mass lesion on radiogram with liver cirrhosis and serum a-fetoprotein level >or=400 ng/mL, UICC stage IV, recurred after any loco-regional treatment, no prior cytotoxic chemotherapy, measurable disease, ECOG performance scale 0~2, age 18~65 year old, adequate bone marrow, cardiac and renal function, total bilirubin

Asunto(s)
Humanos , Bilirrubina , Médula Ósea , Carcinoma Hepatocelular , Cisplatino , Doxorrubicina , Quimioterapia , Quimioterapia Combinada , Cirrosis Hepática , Neutropenia , Estudios Prospectivos , Trombocitopenia
2.
Korean Journal of Nephrology ; : 175-177, 2002.
Artículo en Coreano | WPRIM | ID: wpr-89947

RESUMEN

To date, only one case of peritonitis with exit site infection in peritoneal dialysis caused by this micro- organism has been reported. In spite of its apparently benign clinical course, which distinguished it from peritonitis caused by Pseudomonas, this peritonitis relapsed and Comamonas could not be eliminated from the peritoneal liquid, probably due to the persistence of the micro-organism in the exit site. Consequently, peritoneal catheter was removed. In this case, a 68-year-old man was admitted with fever, abdominal tenderness and cloudy peritoneal effluent and empirically treated with antibiotics(cefazolin, tobramycin), intraperitoneally(IP) for 7 days. The first culture was positive for Comamonas acidovorans, sensitive to ceftazidime, cefotetan, ceftriaxone, ciprofloxaxin and imipenem and the perotoneal effluent remained cloudy after 7 days. He was treated with ceftazidime IP, oral ciprofloxacin and nystatin for 26 days. 4 days after the antibiotics treatment, the patient was asymptomatic and the cell count of peritoneal effluent was 50 WBC/mm3 with negative culture. 25 days after the treatment, the patient remained asymptomatic and with 5 WBC/mm3 in peritoneal effluent. Consequently, We experienced a case of peritonitis due to Comamonas acidovorans in a patient on CAPD without exit site infection and managed with preservation of the catheter.


Asunto(s)
Anciano , Humanos , Antibacterianos , Catéteres , Cefotetán , Ceftazidima , Ceftriaxona , Recuento de Células , Ciprofloxacina , Comamonas , Delftia acidovorans , Fiebre , Imipenem , Nistatina , Diálisis Peritoneal , Diálisis Peritoneal Ambulatoria Continua , Peritonitis , Pseudomonas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA